Relaxink Lidocaine Cream
FDA Label NDC 83714-0004

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Hambli Limited for the product Relaxink Lidocaine (NDC 83714-0004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warnings, dosage & administration, otc - keep out of reach of children, inactive ingredient, indications & usage, otc - purpose, otc - active ingredient, no change yet, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.